AI Article Synopsis
- A systematic review was conducted to assess different lock solutions for non-tunneled hemodialysis catheters, focusing on studies from databases like PubMed and Cochrane.
- Out of 649 studies found, only 6 met the criteria, comparing lock solutions such as citrate, heparin, saline, and ethanol.
- The results indicated no significant difference in catheter survival among lock types, though citrate locks showed fewer infections and complications in some studies, but the data was too varied to recommend a specific solution.
Article Abstract
Background: We conducted a systematic review of studies investigating lock solutions for use in non-tunneled hemodialysis catheters.
Methods: We searched PubMed and Cochrane databases from inception to June 11, 2021. Study inclusion criteria were: randomized trial or observational study, adults (>18 years), with acute kidney injury (AKI); and temporary non-tunneled catheters. We recorded bleeding events, catheter dysfunction and complications.
Results: Of 649 studies identified, 6 were included (4 randomized, 1 non-randomized trial, 1 retrospective cohort study; sample sizes 78-1496 patients). Citrate was compared to heparin in 4 studies, to saline in 1, and ethanol versus saline in 1. Event-free survival of non-tunneled catheters did not differ between groups. Catheter-related infections and adverse events were less frequent with citrate locks, but reached statistical significance in only two studies.
Conclusion: Existing data are too heterogeneous to enable recommending one type of catheter lock over any other for non-tunneled hemodialysis catheters.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092163 | PMC |
| http://dx.doi.org/10.1111/hdi.13047 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Background And Aims: A catheter-related bloodstream infection (CRBSI) is a life-threatening complication of hemodialysis. It is responsible for significant morbidity and mortality and a costly long hospital stay. Despite its burden, little is known about the factors associated with it and the antibiogram of its responsible causative bacteria.
View Article and Find Full Text PDFRisk Factors for Internal Jugular Vein Thrombosis 1 Month After Non-Cuffed Hemodialysis Catheter Removal.
J Clin Med
December 2024
Department of Nephrology, University of Yamanashi Hospital, Yamanashi 400-8506, Japan.
: Complications, namely, catheter-related thrombosis (CRT) and venous stenosis, are associated with non-cuffed hemodialysis catheters used for emergency vascular access. However, only a few reports have demonstrated changes in the venous lumen and intravenous thrombosis after catheter removal. In this study, we comprehensively investigated the risk factors for residual thrombus 1 month after hemodialysis catheter removal.
View Article and Find Full Text PDFEvaluating the use of tunneled hemodialysis catheters in the treatment of acute kidney disease patients requiring hemodialysis: a case-control study.
Int Urol Nephrol
November 2024
Department of Internal Medicine, College of Medicine, Jouf University, 72388, Al Jouf, Saudi Arabia.
Article Synopsis
- This study evaluates the use of tunneled hemodialysis catheters (TDCs) in patients with severe acute kidney disease (AKD) who need hemodialysis, highlighting their effectiveness in comparison to non-tunneled catheters (NTDCs).
- Conducted in Khartoum, Sudan, the research involved 122 adult patients, primarily suffering from conditions like acute tubular necrosis, and assessed various performance metrics and complications associated with TDCs.
- The results demonstrated that TDCs provided significantly better blood flow, fewer complications, and longer functional duration than NTDCs, suggesting TDCs are a safer option for urgent hemodialysis in AKD patients.
Patterns of vascular access among chronic kidney disease patients on maintenance hemodialysis at Muhimbili National Hospital. A single centre cross-sectional study.
PLOS Glob Public Health
November 2024
Renal Unit, Department of Internal Medicine, Muhimbili National Hospital, Dar es Salaam, Tanzania.
Article Synopsis
- * Out of 200 participants, 95.5% started hemodialysis with non-tunneled CVCs, and a significant fraction continued using them due to accessibility and financial issues, despite international guidelines recommending arteriovenous fistulas (AVFs) for better outcomes.
- * The findings point to a critical need for cost analysis and improved efforts to facilitate the use of AVFs in resource-limited settings to enhance patient care and reduce reliance on
The Delay of Recanalisation of Acutely Thrombosed Dialysis Arteriovenous Access Until the Next Workday has No Negative Impact on Clinical Outcome.
Cardiovasc Intervent Radiol
November 2024
Institute of Radiology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Maximiliansplatz 3, 91054, Erlangen, Germany.
Purpose: The necessity of providing endovascular recanalization of acutely thrombosed arteriovenous access (AV access) during weekend is questionable, since hemodialysis can alternatively be achieved by temporarily placed non-tunneled central venous catheters (CVC). Interventional therapy of acutely thrombosed AV access is provided only on weekdays in the study center. This study aimed to compare outcomes in patients admitted on weekdays and on the weekend.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!